Neumora Therapeutics IncNASDAQ:NMRA
- LAST PRICE9.7400
- TODAY'S CHANGE (%)0.0500 (0.5160%)
- Bid / Lots9.6000/ 1
- Ask / Lots10.1100/ 2
- Open / Previous Close9.7900 / 9.6900
- Day Range
- 52 Week Range
- Volume490,167
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NMRA |
|---|---|---|
| 09:32 ET | 4267 | 9.885 |
| 09:33 ET | 2013 | 9.57 |
| 09:35 ET | 1010 | 9.645 |
| 09:37 ET | 2116 | 9.74 |
| 09:39 ET | 900 | 9.695 |
| 09:42 ET | 700 | 9.695 |
| 09:44 ET | 1114 | 9.79 |
| 09:48 ET | 2267 | 9.67 |
| 09:50 ET | 300 | 9.71 |
| 09:53 ET | 1520 | 9.735 |
| 09:55 ET | 300 | 9.8 |
| 09:57 ET | 400 | 9.775 |
| 10:00 ET | 1794 | 9.75 |
| 10:02 ET | 300 | 9.785 |
| 10:06 ET | 1200 | 9.68 |
| 10:08 ET | 660 | 9.71 |
| 10:09 ET | 2910 | 9.755 |
| 10:11 ET | 839 | 9.74 |
| 10:15 ET | 100 | 9.74 |
| 10:18 ET | 500 | 9.71 |
| 10:20 ET | 5550 | 9.74 |
| 10:22 ET | 200 | 9.76 |
| 10:24 ET | 570 | 9.74 |
| 10:26 ET | 3760 | 9.775 |
| 10:27 ET | 1200 | 9.72 |
| 10:29 ET | 1250 | 9.74 |
| 10:33 ET | 6250 | 9.74 |
| 10:36 ET | 915 | 9.76 |
| 10:38 ET | 1400 | 9.8 |
| 10:40 ET | 200 | 9.78 |
| 10:42 ET | 3800 | 9.8 |
| 10:44 ET | 1600 | 9.775 |
| 10:45 ET | 1300 | 9.79 |
| 10:47 ET | 400 | 9.77 |
| 10:49 ET | 200 | 9.76 |
| 10:51 ET | 100 | 9.76 |
| 10:54 ET | 4875 | 9.795 |
| 10:58 ET | 900 | 9.81 |
| 11:02 ET | 376 | 9.8 |
| 11:03 ET | 300 | 9.795 |
| 11:07 ET | 16828 | 9.805 |
| 11:09 ET | 8888 | 9.805 |
| 11:12 ET | 6829 | 9.82 |
| 11:14 ET | 1800 | 9.82 |
| 11:16 ET | 2772 | 9.775 |
| 11:18 ET | 100 | 9.78 |
| 11:20 ET | 100 | 9.78 |
| 11:21 ET | 1243 | 9.74 |
| 11:23 ET | 100 | 9.745 |
| 11:25 ET | 500 | 9.74 |
| 11:27 ET | 100 | 9.74 |
| 11:30 ET | 2328 | 9.74 |
| 11:32 ET | 5262 | 9.74 |
| 11:34 ET | 400 | 9.735 |
| 11:36 ET | 2921 | 9.695 |
| 11:38 ET | 200 | 9.695 |
| 11:39 ET | 450 | 9.7 |
| 11:41 ET | 100 | 9.7 |
| 11:43 ET | 100 | 9.695 |
| 11:45 ET | 2030 | 9.7 |
| 11:48 ET | 2686 | 9.72 |
| 11:50 ET | 850 | 9.75 |
| 11:52 ET | 100 | 9.745 |
| 11:54 ET | 200 | 9.755 |
| 11:56 ET | 3060 | 9.755 |
| 11:57 ET | 523 | 9.77 |
| 11:59 ET | 500 | 9.79 |
| 12:01 ET | 1647 | 9.745 |
| 12:03 ET | 100 | 9.755 |
| 12:06 ET | 400 | 9.75 |
| 12:10 ET | 418 | 9.76 |
| 12:12 ET | 200 | 9.76 |
| 12:14 ET | 500 | 9.755 |
| 12:15 ET | 700 | 9.77 |
| 12:19 ET | 300 | 9.775 |
| 12:21 ET | 7000 | 9.73 |
| 12:24 ET | 1692 | 9.72 |
| 12:26 ET | 1924 | 9.67 |
| 12:28 ET | 200 | 9.66 |
| 12:30 ET | 800 | 9.675 |
| 12:32 ET | 400 | 9.67 |
| 12:33 ET | 100 | 9.675 |
| 12:35 ET | 400 | 9.66 |
| 12:37 ET | 100 | 9.67 |
| 12:39 ET | 777 | 9.66 |
| 12:42 ET | 317 | 9.67 |
| 12:46 ET | 500 | 9.71 |
| 12:48 ET | 400 | 9.73 |
| 12:50 ET | 2376 | 9.72 |
| 12:51 ET | 1300 | 9.74 |
| 12:53 ET | 100 | 9.735 |
| 12:55 ET | 625 | 9.74 |
| 01:00 ET | 100 | 9.74 |
| 01:02 ET | 250 | 9.74 |
| 01:04 ET | 2050 | 9.71 |
| 01:06 ET | 400 | 9.715 |
| 01:08 ET | 652 | 9.71 |
| 01:09 ET | 345 | 9.73 |
| 01:11 ET | 100 | 9.721 |
| 01:15 ET | 138 | 9.73 |
| 01:18 ET | 699 | 9.75 |
| 01:20 ET | 2101 | 9.705 |
| 01:26 ET | 650 | 9.7131 |
| 01:27 ET | 100 | 9.72 |
| 01:29 ET | 700 | 9.71 |
| 01:31 ET | 1338 | 9.69 |
| 01:38 ET | 663 | 9.69 |
| 01:40 ET | 1984 | 9.67 |
| 01:42 ET | 905 | 9.65 |
| 01:44 ET | 521 | 9.65 |
| 01:45 ET | 1285 | 9.64 |
| 01:47 ET | 347 | 9.65 |
| 01:51 ET | 300 | 9.65 |
| 01:54 ET | 200 | 9.65 |
| 01:56 ET | 708 | 9.64 |
| 01:58 ET | 300 | 9.645 |
| 02:02 ET | 1503 | 9.655 |
| 02:03 ET | 503 | 9.6488 |
| 02:09 ET | 219 | 9.66 |
| 02:12 ET | 400 | 9.69 |
| 02:14 ET | 741 | 9.67 |
| 02:18 ET | 500 | 9.65 |
| 02:20 ET | 600 | 9.68 |
| 02:21 ET | 200 | 9.68 |
| 02:25 ET | 691 | 9.69 |
| 02:27 ET | 300 | 9.7 |
| 02:32 ET | 100 | 9.71 |
| 02:34 ET | 200 | 9.73 |
| 02:38 ET | 600 | 9.72 |
| 02:39 ET | 150 | 9.73 |
| 02:41 ET | 1385 | 9.7 |
| 02:43 ET | 1800 | 9.67 |
| 02:48 ET | 1344 | 9.66 |
| 02:50 ET | 200 | 9.67 |
| 02:52 ET | 853 | 9.6609 |
| 02:54 ET | 8819 | 9.65 |
| 02:56 ET | 530 | 9.65 |
| 02:57 ET | 1116 | 9.69 |
| 02:59 ET | 200 | 9.67 |
| 03:01 ET | 1000 | 9.67 |
| 03:03 ET | 677 | 9.66 |
| 03:06 ET | 1400 | 9.615 |
| 03:08 ET | 1485 | 9.65 |
| 03:10 ET | 900 | 9.61 |
| 03:12 ET | 200 | 9.615 |
| 03:14 ET | 5724 | 9.64 |
| 03:15 ET | 400 | 9.6491 |
| 03:17 ET | 600 | 9.65 |
| 03:19 ET | 900 | 9.685 |
| 03:21 ET | 1383 | 9.66 |
| 03:24 ET | 100 | 9.671 |
| 03:26 ET | 900 | 9.695 |
| 03:28 ET | 2342 | 9.695 |
| 03:30 ET | 6215 | 9.7 |
| 03:32 ET | 140 | 9.695 |
| 03:35 ET | 1200 | 9.71 |
| 03:37 ET | 1300 | 9.73 |
| 03:39 ET | 500 | 9.73 |
| 03:42 ET | 1802 | 9.73 |
| 03:44 ET | 3361 | 9.7 |
| 03:46 ET | 850 | 9.708 |
| 03:48 ET | 1826 | 9.72 |
| 03:50 ET | 600 | 9.71 |
| 03:51 ET | 2977 | 9.73 |
| 03:53 ET | 6411 | 9.74 |
| 03:55 ET | 3238 | 9.745 |
| 03:57 ET | 17607 | 9.735 |
| 04:00 ET | 90564 | 9.74 |
Today
Nov 13, 2024
DJ Neumora Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co., from 11:59AM ET on Wednesday Nov 13, 2024 by Dow Jones
11:59AM ET on Wednesday Nov 13, 2024 by Dow JonesDJ Neumora Therapeutics Price Target Maintained With a $23.00/Share by Needham, from 5:20AM ET on Wednesday Nov 13, 2024 by Dow Jones
5:20AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update, from 7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:00AM ET on Tuesday Nov 12, 2024 by Dow JonesPress Release: Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update, from 7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neumora Therapeutics Inc | 1.6B | -5.5x | --- |
Viridian Therapeutics Inc | 1.6B | -4.7x | --- |
Cassava Sciences Inc | 1.5B | -70.2x | --- |
Spyre Therapeutics Inc | 1.4B | -3.7x | --- |
Structure Therapeutics Inc | 1.7B | -15.1x | --- |
Praxis Precision Medicines Inc | 1.4B | -7.2x | --- |
Company Information
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company’s therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Its other candidates include NMRA-266, NMRA-511, and NMRA-NMDA. NMRA-266 is a positive allosteric modulator program of the M4 muscarinic receptor (M4R) for the treatment of schizophrenia. NMRA-266 is designed to be selective for the M4 receptor subtype of the muscarinic receptor family. NMRA-511 is an investigational antagonist of the vasopressin 1a receptor (V1aR). NMRA-NMDA is an NMDA positive allosteric modulator program that the Company is developing for the treatment of schizophrenia.
Contact Information
- Headquarters
- 490 Arsenal Way, Suite 200WATERTOWN, MA, United States 02472
- Phone
- 857-760-0900
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Founder
- Paul Berns
- President, Chief Executive Officer, Director
- Henry Gosebruch
- Co-Founder, Chief Operating Officer
- Carol Suh
- Chief Financial Officer
- Joshua Pinto
- Chief Strategy Officer
- Daljit Aurora
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 160.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.77 |
Book Value | $2.95 |
P/E Ratio | -5.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
